Tessari Eben bought KNSA
September 4, 2025 · Form 4 insider transaction
Tessari Eben bought 46,546 shares of Kiniksa Pharmaceuticals International, plc at $15.52 per share, a transaction worth $722.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
46,546
Price
$15.52
Total value
$722.4K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateSeptember 4, 2025
Filing dateSeptember 8, 2025
Shares owned after129,723
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.